Eur Rev Med Pharmacol Sci 2018; 22 (18): 5769-5770
DOI: 10.26355/eurrev_201809_15900

MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3. It is a cost-effective genetic test

S. Di Martino, C. Di Iorio, G. Marotta

Pathology Unit, Cav. Apicella Hospital, Pollena Trocchia (ASL NA 3 SUD), Naples, Italy. salvo-dimartino@libero.it

Free PDF Download

To cite this article

S. Di Martino, C. Di Iorio, G. Marotta
MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3. It is a cost-effective genetic test

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 18
Pages: 5769-5770
DOI: 10.26355/eurrev_201809_15900

Keywords Related articles:

  1. MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3
  2. MASTL is a potential poor prognostic indicator in ER+ breast cancer
  3. Comment on “Tegafur gimeracil oter combined with oxaliplatin for advanced colorectal cancer.” Is it cost effectiveness?
  4. Genome-wide analysis of genetic variations assisted by Ingenuity Pathway Analysis to comprehensively investigate potential genetic targets associated with the progression of hepatocellular carcinoma
  5. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer